Organization (Nonprofit)
Sanford Health
ClinicalTrials.gov lists Sanford Health as lead sponsor of 41 trials, counting the companies grouped under it. Sanford Health itself has 32 active development programs and 12 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Sanford Health and 1 company grouped under it: 41 lead-sponsored trials (39 its own, 2 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).
Companies grouped under this page (1)
| Company | Lead trials | Legal entities |
|---|---|---|
| Sanford Research | 2 | 1 |
Disease areas (182)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Head and Neck Neoplasms | 4 |
| Knee Injuries | 4 |
| Anterior Cruciate Ligament Injuries | 3 |
| Aortic Aneurysm | 3 |
| Breast Neoplasms | 3 |
Showing 5 of 182 disease areas.
Trials by start year as sponsor or collaborator (18)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2024 | 2 |
| 2023 | 4 |
| 2022 | 5 |
| 2021 | 4 |
| 2020 | 3 |
| 2019 | 2 |
| 2018 | 7 |
| 2017 | 3 |
| 2016 | 4 |
Showing 10 of 18 years.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (32)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| +/- Bupivacaine HCl | Ankle Injuries | Phase 2 | 1 |
| bupivacaine hydrochloride and betamethasone sodium phosphate | Ankle Injuries | Phase 2 | 1 |
| Radiation | Hypopharyngeal Neoplasms | Phase 1 | 1 |
| Radiation | Carcinoma, Squamous Cell | Phase 1 | 1 |
| Radiation | Head and Neck Neoplasms | Phase 1 | 1 |
Showing 5 of 32 active programs.
Approved assets (12)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Acetaminophen 325Mg Tab | 1 |
| Ibuprofen 600 mg | 1 |
| ChloraPrep | 1 |
| Norco 5Mg-325Mg Tablet | 1 |
| Calcium/Vitamin D | 2 |
Showing 5 of 12 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 67% hit target (n=12) | 25% on time (n=12) |
Journals published in (111)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery | 14 |
| Obesity (Silver Spring, Md.) | 11 |
| The New England journal of medicine | 8 |
| Pediatrics | 7 |
| Lancet (London, England) | 6 |
Showing 5 of 111 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 71 | 24 | 2025-09-16 |
Organization relationships (162)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Curing Retinal Blindness Foundation | Co sponsors trial with | 1 |
| Maple Syrup Urine Disease Family Support Group | Co sponsors trial with | 1 |
| University of Colorado System | Co sponsors trial with | 1 |
| University of Michigan | Co sponsors trial with | 1 |
| Batten Disease Support and Research Association | Co sponsors trial with | 1 |
Showing 5 of 162 relationships.
Latest dated events (132)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-16 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-05-27 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-04-15 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 132 events.
CLIA clinical laboratory certificates (2)
Shown in this order: active first, then certificate type.
| Lab | Certificate | Status |
|---|---|---|
| SANFORD HEALTH | Certificate of waiver | Active |
| SANFORD HEALTH | Certificate of waiver | Terminated |
Biomarker capability evidence (29)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| ALB | Trial sponsor | Named in trial inclusion criteria |
| EPO | Trial sponsor | Named in trial inclusion criteria |
| EPX | Trial sponsor | Named in trial inclusion criteria |
| ERBB2 | Trial sponsor | Named in trial inclusion criteria |
| PGR | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 29 evidence rows.
Biomarkers this organization publishes on (3)
Shown in this order: most publications first.
On Scientist.com
Sanford Health is listed as a research supplier in the Scientist.com network.
- Website
- www.sanfordhealth.org
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.
Work with Sanford Health on Scientist.com
For prices, more details, or to contact Sanford Health, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.